Cancer Gene Therapy - Table of Contents alert Volume 24 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 24, Issue 2 (February 2017) In this issue Short Communication Reviews Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Short Communication Top OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro S Yano, K Takehara, H Kishimoto, H Tazawa, Y Urata, S Kagawa, M Bouvet, T Fujiwara and R M Hoffman Cancer Gene Ther 2017 24: 45-47; advance online publication, January 20, 2017; 10.1038/cgt.2016.67 Abstract | Full Text Reviews Top Molecular imaging and cancer gene therapy Z Saadatpour, G Bjorklund, S Chirumbolo, M Alimohammadi, H Ehsani, H Ebrahiminejad, H Pourghadamyari, B Baghaei, H R Mirzaei, A Sahebkar, H Mirzaei and M Keshavarzi Cancer Gene Ther 2017 24: 48-52; advance online publication, November 18, 2016; 10.1038/cgt.2016.62 Abstract | Full Text Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer R Nedaeinia, M Manian, M H Jazayeri, M Ranjbar, R Salehi, M Sharifi, F Mohaghegh, M Goli, S H Jahednia, A Avan and M Ghayour-Mobarhan Cancer Gene Ther 2017 24: 53-61; advance online publication, December 16, 2016; 10.1038/cgt.2016.77 Abstract | Full Text Original Articles Top Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer OPEN X Yan, S-C Jiao, G-Q Zhang, Y Guan and J-L Wang Cancer Gene Ther 2017 24: 62-68; advance online publication, January 13, 2017; 10.1038/cgt.2016.40 Abstract | Full Text Stable knockdown of CREB, HIF-1 and HIF-2 by replication-competent retroviruses abrogates the responses to hypoxia in hepatocellular carcinoma OPEN D Shneor, R Folberg, J Pe'er, A Honigman and S Frenkel Cancer Gene Ther 2017 24: 69-79; advance online publication, December 9, 2016; 10.1038/cgt.2016.68 Abstract | Full Text Apoptosis-inducing and antiproliferative effect by inhibition of miR-182-5p through the regulation of CASP9 expression in human breast cancer M Sharifi and A Moridnia Cancer Gene Ther 2017 24: 80-87; advance online publication, January 13, 2017; 10.1038/cgt.2016.79 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.